Nancy L Mora Becerra1,2, Bradley Needleman3, Sabrena Noria3, David Bradley1. 1. Dorothy M. Davis Heart and Lung Research Institute, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, OH, United States. 2. Department of Medicine, Division of Endocrinology, Diabetes & Metabolism, Ronald Reagan UCLA Medical Center, Los Angeles, CA, United States. 3. The Center for Minimally Invasive Surgery, Department of Surgery, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
Abstract
CONTEXT: The prevalence of obstructive sleep apnea (OSA) increases with obesity, and OSA has been linked to increased cardiovascular risk via hypoxemia and sleep disruption. OBJECTIVE AND MAIN OUTCOME MEASURES: We hypothesized that if OSA contributes to cardio-metabolic risk, then 1) obese individuals with OSA will have more cardio-metabolic disease, and 2) patients with OSA who are non-adherent to CPAP treatment will have a greater incidence of cardio-metabolic abnormalities. DESIGN SETTING AND PATIENTS: We prospectively recruited obese patients (n = 83; BMI 49 ± 9 kg/m2). All patients had polysomnography and were stratified by 1) the absence/presence of OSA, and 2) metabolic health. Detailed CPAP reports were analyzed for compliance and OSA severity in 38 subjects. RESULTS: OSA by polysomnography was present in 69% of patients. While 79% of patients with OSA and 54% without OSA were categorized as MAO (χ2 = 5.47, p < 0.02), when adjusted for age, gender and BMI this difference was not significant (p = 0.36). Insulin levels were higher in the OSA group, but when adjusted there was no significant difference (p = 0.350). In patients on CPAP therapy, there was a negative associative trend between OSA control (apnea-hypopnea index) and beta-cell function (HOMA-β) (r = -0.406, p = 0.076), but no association between CPAP compliance and AHI with age, BMI, glucose, insulin, adiponectin, or insulin resistance. CONCLUSIONS: OSA is not independently associated with overall cardio-metabolic health and insulin resistance in obese patients, even when accounting for treatment compliance. The strongest predictors of the obese metabolic healthy phenotype in OSA patients are age, gender and BMI.
CONTEXT: The prevalence of obstructive sleep apnea (OSA) increases with obesity, and OSA has been linked to increased cardiovascular risk via hypoxemia and sleep disruption. OBJECTIVE AND MAIN OUTCOME MEASURES: We hypothesized that if OSA contributes to cardio-metabolic risk, then 1) obese individuals with OSA will have more cardio-metabolic disease, and 2) patients with OSA who are non-adherent to CPAP treatment will have a greater incidence of cardio-metabolic abnormalities. DESIGN SETTING AND PATIENTS: We prospectively recruited obese patients (n = 83; BMI 49 ± 9 kg/m2). All patients had polysomnography and were stratified by 1) the absence/presence of OSA, and 2) metabolic health. Detailed CPAP reports were analyzed for compliance and OSA severity in 38 subjects. RESULTS: OSA by polysomnography was present in 69% of patients. While 79% of patients with OSA and 54% without OSA were categorized as MAO (χ2 = 5.47, p < 0.02), when adjusted for age, gender and BMI this difference was not significant (p = 0.36). Insulin levels were higher in the OSA group, but when adjusted there was no significant difference (p = 0.350). In patients on CPAP therapy, there was a negative associative trend between OSA control (apnea-hypopnea index) and beta-cell function (HOMA-β) (r = -0.406, p = 0.076), but no association between CPAP compliance and AHI with age, BMI, glucose, insulin, adiponectin, or insulin resistance. CONCLUSIONS: OSA is not independently associated with overall cardio-metabolic health and insulin resistance in obese patients, even when accounting for treatment compliance. The strongest predictors of the obese metabolic healthy phenotype in OSA patients are age, gender and BMI.
Authors: Jamie C M Lam; Bing Lam; Chi-Leung Lam; Daniel Fong; Julie K L Wang; Hung-Fat Tse; Karen S L Lam; Mary S M Ip Journal: Respir Med Date: 2005-12-05 Impact factor: 3.415
Authors: Naresh M Punjabi; John D Sorkin; Leslie I Katzel; Andrew P Goldberg; Alan R Schwartz; Philip L Smith Journal: Am J Respir Crit Care Med Date: 2002-03-01 Impact factor: 21.405
Authors: Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers Journal: Arch Intern Med Date: 2008-08-11
Authors: O Marrone; A Salvaggio; M Gioia; A Bonanno; M Profita; L Riccobono; A Zito; G Insalaco; M R Bonsignore Journal: Monaldi Arch Chest Dis Date: 2008-09